Varma Mutual Pension Insurance Co Acquires 34,200 Shares of Kenvue Inc. $KVUE

Varma Mutual Pension Insurance Co lifted its holdings in Kenvue Inc. (NYSE:KVUE) by 8.8% in the 3rd quarter, Holdings Channel.com reports. The firm owned 423,166 shares of the company’s stock after acquiring an additional 34,200 shares during the quarter. Varma Mutual Pension Insurance Co’s holdings in Kenvue were worth $6,868,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Cornerstone Planning Group LLC boosted its position in Kenvue by 705.2% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after acquiring an additional 1,361 shares in the last quarter. NBT Bank N A NY lifted its stake in shares of Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares during the last quarter. Salomon & Ludwin LLC bought a new stake in Kenvue during the third quarter valued at about $25,000. Golden State Wealth Management LLC grew its stake in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after purchasing an additional 1,190 shares during the last quarter. Finally, Trust Co. of Vermont raised its holdings in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on KVUE. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and reduced their price target for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Johnson Rice reiterated a “neutral” rating on shares of Kenvue in a report on Tuesday, October 28th. Barclays boosted their target price on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Four analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Kenvue has an average rating of “Hold” and a consensus price target of $19.46.

Insider Activity at Kenvue

In other news, Director Jeffrey C. Smith bought 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were purchased at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.68% of the stock is owned by company insiders.

Kenvue Stock Performance

Shares of KVUE stock opened at $18.70 on Friday. The firm has a market capitalization of $35.82 billion, a price-to-earnings ratio of 24.93 and a beta of 0.59. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The business has a fifty day moving average of $17.38 and a 200 day moving average of $17.76. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th will be paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.4%. The ex-dividend date is Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is presently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.